Authors:
Sawada, M
Nakashima, S
Kiyono, T
Nakagawa, M
Yamada, J
Yamakawa, H
Banno, Y
Shinoda, J
Nishimura, Y
Nozawa, Y
Sakai, N
Citation: M. Sawada et al., p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells, ONCOGENE, 20(11), 2001, pp. 1368-1378
Authors:
Ahmed, CMI
Johnson, DE
Demers, GW
Engler, H
Howe, JA
Wills, KN
Wen, SF
Shinoda, J
Beltran, J
Nodelman, M
Machemer, T
Maneval, DC
Nagabhushan, TL
Sugarman, BJ
Citation: Cmi. Ahmed et al., Interferon alpha 2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers, CANC GENE T, 8(10), 2001, pp. 788-795
Authors:
Shinoda, J
Sakai, N
Murase, S
Yano, H
Matsuhisa, T
Funakoshi, T
Citation: J. Shinoda et al., Selection of eligible patients with supratentorial glioblastoma multiformefor gross total resection, J NEURO-ONC, 52(2), 2001, pp. 161-171
Authors:
Minter, RM
Ferry, MA
Murday, ME
Tannahill, CL
Bahjat, FR
Oberholzer, C
Oberholzer, A
LaFace, D
Hutchins, B
Wen, SF
Shinoda, J
Copeland, EM
Moldawer, LL
Citation: Rm. Minter et al., Adenoviral delivery of human and viral IL-10 in murine sepsis, J IMMUNOL, 167(2), 2001, pp. 1053-1059
Authors:
Sawada, M
Nakashima, S
Banno, Y
Yamakawa, H
Takenaka, K
Shinoda, J
Nishimura, Y
Sakai, N
Nozawa, Y
Citation: M. Sawada et al., Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells, ONCOGENE, 19(31), 2000, pp. 3508-3520
Authors:
Swaroop, GR
Kelly, PAT
Bell, HS
Shinoda, J
Yamaguchi, S
Whittle, IR
Citation: Gr. Swaroop et al., The effects of chronic nitric oxide synthase suppression on glioma pathophysiology, BR J NEUROS, 14(6), 2000, pp. 543-548
Authors:
Yano, H
Hara, A
Takenaka, K
Nakatani, K
Shinoda, J
Shimokawa, K
Yoshimi, N
Mori, H
Sakai, N
Citation: H. Yano et al., Differential expression of beta-catenin in human glioblastoma multiforme and normal brain tissue, NEUROL RES, 22(7), 2000, pp. 650-656
Authors:
Murase, S
Saio, M
Andoh, H
Takenaka, K
Shinoda, J
Nishimura, Y
Sakai, N
Takami, T
Citation: S. Murase et al., Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients, NEUROL RES, 22(5), 2000, pp. 434-442
Authors:
Yano, H
Hara, A
Shinoda, J
Takenaka, K
Yoshimi, N
Mori, H
Sakai, N
Citation: H. Yano et al., Immunohistochemical analysis of beta-catenin in N-ethyl-N-nitrosourea-induced rat gliomas: Implications in regulation of angiogenesis, NEUROL RES, 22(5), 2000, pp. 527-532
Authors:
Okumura, A
Takenaka, K
Nishimura, Y
Kawaguchi, M
Yamakawa, H
Shinoda, J
Deguchi, K
Sakai, N
Citation: A. Okumura et al., Intra-operative optical method using intrinsic signals for localization ofsensorimotor area in patients with brain tumor, NEUROL RES, 21(6), 1999, pp. 545-552
Authors:
Okumura, A
Takenaka, K
Nishimura, Y
Kawaguchi, M
Asano, Y
Yamakawa, H
Hattori, T
Shinoda, J
Andou, T
Sakai, N
Citation: A. Okumura et al., Functional MR imaging with venography for neurosurgical identification of the central sulcus, NEUROL RES, 21(2), 1999, pp. 185-190
Authors:
Murase, S
Saio, M
Takenaka, K
Shinoda, J
Nishimura, Y
Sakai, N
Takami, T
Citation: S. Murase et al., Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma, CANCER LETT, 132(1-2), 1998, pp. 181-186